Lumenis Executive and Leadership Team

Masako Uchida, the President at Lumenis, oversees the strategic expansion of the company within the Asian market, focusing on the adoption of energy-based skin and eye care solutions. Uchida directs regional sales strategies and manages relationships with key clinical partners to increase the market penetration of the Digital Duet platform. By aligning regional business goals with the overarching corporate mission, the President ensures consistent revenue growth and brand positioning. This leadership role involves navigating complex regulatory environments to facilitate the rapid deployment of new medical technologies. Masako Uchida drives operational excellence by optimizing local distribution networks and enhancing customer support services. Through the cultivation of high-performing regional teams, the President maintains a strong competitive presence in the medical aesthetics industry. This focus on regional market development supports the global objective of delivering advanced, energy-based treatments to a broader patient base.

James Taylor, the President at Lumenis, manages the commercial operations and strategic growth initiatives across the North American market. Taylor directs the implementation of sales programs for the Stellar M22 and OptiLight product lines, ensuring alignment with clinical demand and market trends. By overseeing the expansion of professional training programs, the President enhances the adoption of energy-based technologies among dermatologists and ophthalmologists. This leadership role involves close collaboration with the executive board to refine long-term business strategies and improve operational efficiency. James Taylor drives revenue growth by identifying new market opportunities and strengthening partnerships with major medical centers. Through the effective management of regional sales forces, the President ensures that the company maintains a dominant position in the medical device sector. This strategic focus on North American operations directly contributes to the overall financial stability and market influence of the organization.

Tahel Blum, the Chief Information Officer at Lumenis, architects the digital infrastructure supporting global manufacturing and commercial operations. Blum manages the enterprise resource planning systems that track the distribution of Trilift and OptiPlus devices across international markets. By implementing robust cybersecurity protocols, the Chief Information Officer protects sensitive clinical data and proprietary research assets. This leadership role requires seamless coordination with regional IT teams to ensure operational continuity across the European and North American business units. Tahel Blum drives digital transformation initiatives, streamlining supply chain visibility and enhancing data-driven decision-making for the executive board. Through the modernization of internal communication platforms, the Chief Information Officer fosters cross-departmental efficiency. This strategic oversight of information technology systems directly supports the scalability of the company, ensuring that digital tools remain aligned with the rapid growth of the medical device sector.

May Kleinman, the Director, Technologies at Lumenis, manages the research and development lifecycle for energy-based medical platforms. Kleinman directs the engineering teams responsible for the evolution of the Stellar M22 and OptiLight systems, ensuring all hardware meets rigorous international safety standards. By overseeing the integration of advanced light-based energy into clinical workflows, the Director, Technologies optimizes product performance for dermatological and ophthalmic applications. This role involves constant collaboration with clinical researchers to refine treatment efficacy across diverse patient demographics. May Kleinman drives the technical roadmap, aligning engineering milestones with the broader corporate objective of market leadership in aesthetic and surgical technology. Through the continuous improvement of proprietary energy delivery mechanisms, the Director, Technologies secures the competitive advantage of the product portfolio. This technical leadership ensures that every device manufactured provides consistent, high-quality outcomes for practitioners worldwide.